Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 117

Similar articles for PubMed (Select 24033843)

1.

Outcomes of combination therapy for chronic antibody-mediated rejection in renal transplantation.

Kim MG, Kim YJ, Kwon HY, Park HC, Koo TY, Jeong JC, Jeon HJ, Han M, Ahn C, Yang J.

Nephrology (Carlton). 2013 Dec;18(12):820-6. doi: 10.1111/nep.12157.

PMID:
24033843
2.

Effectiveness of rituximab and intravenous immunoglobulin therapy in renal transplant recipients with chronic active antibody-mediated rejection.

Hong YA, Kim HG, Choi SR, Sun IO, Park HS, Chung BH, Choi BS, Park CW, Kim YS, Yang CW.

Transplant Proc. 2012 Jan;44(1):182-4. doi: 10.1016/j.transproceed.2011.12.006.

PMID:
22310610
3.
4.

Successful treatment of chronic antibody-mediated rejection with IVIG and rituximab in pediatric renal transplant recipients.

Billing H, Rieger S, Ovens J, Süsal C, Melk A, Waldherr R, Opelz G, Tönshoff B.

Transplantation. 2008 Nov 15;86(9):1214-21. doi: 10.1097/TP.0b013e3181880b35.

PMID:
19005402
5.

Frequent development of subclinical chronic antibody-mediated rejection within 1 year after renal transplantation with pre-transplant positive donor-specific antibodies and negative CDC crossmatches.

Yamanaga S, Watarai Y, Yamamoto T, Tsujita M, Hiramitsu T, Nanmoku K, Goto N, Takeda A, Morozumi K, Katayama A, Saji H, Uchida K, Kobayashi T.

Hum Immunol. 2013 Sep;74(9):1111-8. doi: 10.1016/j.humimm.2013.06.022. Epub 2013 Jun 18.

PMID:
23792054
6.

Intensive plasmapheresis and intravenous immunoglobulin for treatment of antibody-mediated rejection after kidney transplant.

Ruangkanchanasetr P, Satirapoj B, Termmathurapoj S, Namkhanisorn K, Suaywan K, Nimkietkajorn V, Luesutthiviboon L.

Exp Clin Transplant. 2014 Aug;12(4):328-33.

7.

Comparison between bortezomib and rituximab in the treatment of antibody-mediated renal allograft rejection.

Waiser J, Budde K, Schütz M, Liefeldt L, Rudolph B, Schönemann C, Neumayer HH, Lachmann N.

Nephrol Dial Transplant. 2012 Mar;27(3):1246-51. doi: 10.1093/ndt/gfr465. Epub 2011 Aug 17.

8.

Differential modulation of donor-specific antibodies after B-cell depleting therapies to cure chronic antibody mediated rejection.

Touzot M, Couvrat-Desvergnes G, Castagnet S, Cesbron A, Renaudin K, Cantarovich D, Giral M.

Transplantation. 2015 Jan;99(1):63-8. doi: 10.1097/TP.0000000000000285.

PMID:
25029384
9.

Late antibody-mediated rejection in renal allografts: outcome after conventional and novel therapies.

Gupta G, Abu Jawdeh BG, Racusen LC, Bhasin B, Arend LJ, Trollinger B, Kraus E, Rabb H, Zachary AA, Montgomery RA, Alachkar N.

Transplantation. 2014 Jun 27;97(12):1240-6. doi: 10.1097/01.TP.0000442503.85766.91.

PMID:
24937198
10.

The effect of combination therapy with rituximab and intravenous immunoglobulin on the progression of chronic antibody mediated rejection in renal transplant recipients.

An GH, Yun J, Hong YA, Khvan M, Chung BH, Choi BS, Park CW, Choi YJ, Kim YS, Yang CW.

J Immunol Res. 2014;2014:828732. doi: 10.1155/2014/828732. Epub 2014 Jan 29.

11.

Reduction of alloantibodies via proteasome inhibition in cardiac transplantation.

Patel J, Everly M, Chang D, Kittleson M, Reed E, Kobashigawa J.

J Heart Lung Transplant. 2011 Dec;30(12):1320-6. doi: 10.1016/j.healun.2011.08.009. Epub 2011 Oct 2.

PMID:
21968130
12.

Antibody-mediated rejection and treatment in pediatric patients: one center's experience.

Gulleroglu K, Baskin E, Bayrakci US, Turan M, Ozdemir BH, Moray G, Karakayali H, Haberal M.

Exp Clin Transplant. 2013 Oct;11(5):404-7.

13.

Four-year allograft survival in a highly sensitized combined liver-kidney transplant patient despite unsuccessful anti-HLA antibody reduction with rituximab, splenectomy, and bortezomib.

Koch M, Gräser C, Lehnhardt A, Pollok JM, Kröger N, Verboom M, Thaiss F, Eiermann T, Nashan B.

Transpl Int. 2013 Aug;26(8):e64-8. doi: 10.1111/tri.12120. Epub 2013 May 15.

PMID:
23672514
14.

Efficacy of bortezomib for reducing donor-specific antibodies in children and adolescents on a steroid minimization regimen.

Nguyen S, Gallay B, Butani L.

Pediatr Transplant. 2014 Aug;18(5):463-8. doi: 10.1111/petr.12274. Epub 2014 May 12.

PMID:
24814755
15.

IVIG and rituximab for treatment of chronic antibody-mediated rejection: a prospective study in paediatric renal transplantation with a 2-year follow-up.

Billing H, Rieger S, Süsal C, Waldherr R, Opelz G, Wühl E, Tönshoff B.

Transpl Int. 2012 Nov;25(11):1165-73. doi: 10.1111/j.1432-2277.2012.01544.x. Epub 2012 Aug 17.

PMID:
22897111
16.

Indicators of treatment responsiveness to rituximab and plasmapheresis in antibody-mediated rejection after kidney transplantation.

Immenschuh S, Zilian E, Dämmrich ME, Schwarz A, Gwinner W, Becker JU, Blume CA.

Transplantation. 2015 Jan;99(1):56-62. doi: 10.1097/TP.0000000000000244.

PMID:
25121474
17.

Rapid reduction in donor-specific anti-human leukocyte antigen antibodies and reversal of antibody-mediated rejection with bortezomib in pediatric heart transplant patients.

Morrow WR, Frazier EA, Mahle WT, Harville TO, Pye SE, Knecht KR, Howard EL, Smith RN, Saylors RL, Garcia X, Jaquiss RD, Woodle ES.

Transplantation. 2012 Feb 15;93(3):319-24. doi: 10.1097/TP.0b013e31823f7eea.

18.

Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection.

Walsh RC, Everly JJ, Brailey P, Rike AH, Arend LJ, Mogilishetty G, Govil A, Roy-Chaudhury P, Alloway RR, Woodle ES.

Transplantation. 2010 Feb 15;89(3):277-84. doi: 10.1097/TP.0b013e3181c6ff8d.

PMID:
20145517
19.

Long-term outcomes of kidney transplantation across a positive complement-dependent cytotoxicity crossmatch.

Riella LV, Safa K, Yagan J, Lee B, Azzi J, Najafian N, Abdi R, Milford E, Mah H, Gabardi S, Malek S, Tullius SG, Magee C, Chandraker A.

Transplantation. 2014 Jun 27;97(12):1247-52. doi: 10.1097/01.TP.0000442782.98131.7c.

PMID:
24854670
20.

Acute antibody-mediated rejection in paediatric renal transplant recipients.

Kranz B, Kelsch R, Kuwertz-Bröking E, Bröcker V, Wolters HH, Konrad M.

Pediatr Nephrol. 2011 Jul;26(7):1149-56. doi: 10.1007/s00467-011-1864-3. Epub 2011 Apr 1.

PMID:
21461632
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk